Lenacapavir Manufacturing In SA: Strengthening Production
Lenacapavir manufacturing in SA aims to strengthen supply chains and provide critical HIV prevention solutions.
HIV Prevention Shot Lenacapavir: Aspen Warns of Demand Risks
Learn about the HIV prevention shot lenacapavir and why Aspen Pharmacare emphasises guaranteed demand for local production.
Generic Lenacapavir Manufacturing: SA’s Bold 2027 Strategy
South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.
Lenacapavir in Short Supply Amid HIV Epidemic in Africa
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
Gilead’s Lenacapavir to Reach High-Burden Nations ‘At Cost’
Gilead’s Lenacapavir is set to revolutionise HIV prevention efforts, aiming to protect two million people across affected nations.
Twice-Yearly HIV Jab: Activists Call for Lower Prices
Explore the revolutionary Twice-Yearly HIV Jab, a potential game-changer in HIV prevention that raises important affordability questions.